Skip to content
PeptideGeek

Hormones

Leuprolide, explained simply

An injection that dials down the body's sex-hormone production, used to manage prostate cancer, endometriosis, and early puberty.

Well studied in peopleInjection under the skin (like insulin shots)7 cited sources

Start here

What is Leuprolide?

Leuprolide is an FDA-approved medicine that shuts down the body's production of sex hormones — testosterone in men, estrogen in women. After a brief initial surge, it exhausts the pituitary (the master hormone gland at the base of the brain)'s signaling system and locks hormone output in the off position 1. It is used for prostate cancer 5, endometriosis pain 6, uterine fibroids before surgery 6, and early puberty in children 7, with long-acting injections that last one to several months 5.

How it works in your body

Leuprolide works by pretending to be your brain's natural GnRH hormone, but in a way that confuses your pituitary (the master hormone gland at the base of the brain) gland. For the first week, it actually stimulates hormone production, but then your body gets exhausted and shuts down the whole system. This stops testosterone in men and estrogen in women—exactly what you need for hormone-sensitive conditions like prostate cancer and endometriosis. Think of it as a switch that flips on briefly, then locks in the off position 1.

The deeper mechanism, for the curious

Leuprolide is a lab-made nonapeptide (a chain of nine amino acids: pyroGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt) that strongly activates GnRH receptors (docking sites for the brain hormone that controls sex hormones). 14 After an injection under the skin or into a muscle, leuprolide binds GnRH receptors in the anterior pituitary (the front part of the pituitary gland at the base of the brain) very tightly. At first it acts like the natural hormone and quickly releases luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This briefly raises testosterone, a surge called a 'flare.' But constant exposure makes the receptors stop responding and drop in number (desensitization and downregulation (dials down activity)) within 7-14 days, which deeply suppresses gonadotropin (the hormones that signal the testes and ovaries) secretion (the release of LH and FSH). Without LH, the Leydig cells (testosterone-making cells in the testes) in males get no signal to make testosterone. Without FSH and LH, the ovaries in females get no signal to make estrogen. Testosterone and estrogen levels typically drop 90-95% within 2-4 weeks. The suppression lasts as long as the medicine is given. Leuprolide's half-life (the time for half the drug to leave the body) is 2-3 hours for daily forms, but depot formulations (slow-release injections) with fatty acid conjugation (a fatty chain attached to the drug) have extended half-lives of 2-5 weeks, so doses can be monthly to quarterly through slow release. 2

Evidence check

Well studied in people

This has been through large human trials — the strongest kind of evidence. Scientists have tested it on many people and measured what actually happened.

Every numbered marker on this page links to one of the 7 sources at the bottom.

94/100

Cancer Management

Effectively reduces testosterone in men with prostate cancer

90/100

Endometriosis & Fibroid Relief

Relieves severe endometriosis pain and symptoms

87/100

Hormone Control

Reversible hormone suppression with minimal long-term effects

What the research points to

The most-asked question

How much Leuprolide do I take?

The research-reported range is 1 mg, once daily. Studies used different doses for different situations — find yours:

  1. Advanced prostate cancer, Daily dosing option

    1 mg

    • How often
      Once daily
    • For how long
      Ongoing
    • How
      Injection under the skin

    The original daily form is a 1 mg shot under the skin each day for advanced prostate cancer. It works but needs a shot every day, so most people now use the longer-acting depot instead 4.

  2. Advanced prostate cancer, Monthly convenience

    7.5 mg

    • How often
      Every month
    • For how long
      Ongoing
    • How
      Injection into a muscle

    The 1-month depot is a single 7.5 mg shot into the muscle every 4 weeks. One injection replaces a month of daily shots 5.

  3. Advanced prostate cancer, Fewer injections

    22.5 mg

    • How often
      Every 3 months
    • For how long
      Ongoing
    • How
      Injection into a muscle

    The 3-month depot is a 22.5 mg muscle injection given once every 3 months, so fewer office visits 5.

  4. Advanced prostate cancer, Long-term maintenance

    30-45 mg

    • How often
      Every 4-6 months
    • For how long
      Ongoing
    • How
      Injection into a muscle

    The longest-acting depots: 30 mg every 4 months, or 45 mg every 6 months. These need only 2-3 injections per year 5.

Every studied protocol, drawn on one scale — 0 to 45 mg.
  1. Advanced prostate cancer, Daily dosing option1 mg
  2. Advanced prostate cancer, Monthly convenience7.5 mg
  3. Advanced prostate cancer, Fewer injections22.5 mg
  4. Advanced prostate cancer, Long-term maintenance30-45 mg

Adjusting your dose

You're at the right dose if…

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Consider going up if…

  • You've tolerated the current dose for the recommended period without significant side effects
  • Therapeutic goals haven't been met at the current dose level
  • Your healthcare provider recommends dose escalation based on your response
  • Lab work or clinical assessments support a higher dose

Go down if…

  • Side effects are bothersome or impacting daily life despite management strategies
  • You experience any signs of an adverse reaction
  • Lab results indicate the need for dose reduction
  • Your healthcare provider recommends a lower dose based on your response

The ceiling: 45 mg (as determined by your healthcare provider based on individual response and tolerance) 5

Reconstitution, in plain words

How do I mix Leuprolide?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Leuprolide:

What you need

  • Leuprolide vial (lyophilized powder or solution)
  • Bacteriostatic water or sterile sodium chloride for reconstitution
  • Alcohol swabs for cleaning vial tops and injection sites
  • Appropriately sized syringes with fine-gauge needles (27-30 gauge)
  • Sharps disposal container

A worked example

Add the recommended volume of bacteriostatic water to the Leuprolide vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Working out your dose

Your dose of Leuprolide is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Leuprolide's recorded schedule.

LeuprolideOnce daily

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Injection sites & technique

Where do I inject Leuprolide?

The best spots

  • Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
  • Front of thighs—middle to upper portion of the outer leg
  • Back of upper arm—outer area (may need assistance from another person)

How to do it, step by step

  • Wash your hands thoroughly with soap and water before handling supplies
  • Clean the injection site with an alcohol swab and let it air dry completely
  • Pinch a fold of skin at the chosen injection site
  • Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
  • Inject the medication slowly and steadily over 5-10 seconds
  • Release the skin fold and remove the needle, applying gentle pressure with a clean swab
  • Rotate injection sites to prevent tissue irritation or lipodystrophy (lumps or dents in fatty tissue)
  • Dispose of the needle safely in a sharps container—never recap or reuse needles

Subcutaneous (under the skin) injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Timing

When do I take Leuprolide?

Best time of day

Administer Leuprolide at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.

With or without food?

Leuprolide injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.

Taking it with other peptides

Leuprolide should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

The honest list

What side effects could Leuprolide cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

  • Hot flashes (very common in men)

    Hot flashes (very common in men)

    What to do Consult your healthcare provider for guidance.

  • Lower sex drive and trouble getting an erection (erectile dysfunction)

    Decreased libido and erectile dysfunction

    What to do Consult your healthcare provider for guidance.

  • Injection site pain or swelling

    Injection site pain or swelling

    What to do Consult your healthcare provider for guidance.

  • Nausea

    Nausea

    What to do Consult your healthcare provider for guidance.

  • Fatigue

    Fatigue

    What to do Consult your healthcare provider for guidance.

  • Mood changes or depression

    Mood changes or depression

    What to do Consult your healthcare provider for guidance.

  • Joint or muscle pain

    Joint or muscle pain

    What to do Consult your healthcare provider for guidance.

  • Headaches

    Headaches

    What to do Consult your healthcare provider for guidance.

  • Dizziness

    Dizziness

    What to do Consult your healthcare provider for guidance.

  • Thinning hair

    Thinning hair

    What to do Consult your healthcare provider for guidance.

  • Weaker bones (decreased bone density; osteoporosis with long-term use)

    Decreased bone density (osteoporosis with long-term use)

    What to do Consult your healthcare provider for guidance.

  • QT prolongation (a heart rhythm change; rare but serious)

    QT prolongation (rare but serious cardiac effect)

    What to do Consult your healthcare provider for guidance.

  • Tumor flare (temporary worsening of cancer symptoms in first weeks)

    Tumor flare (temporary worsening of cancer symptoms in first weeks) 15

    What to do Consult your healthcare provider for guidance.

  • Severe allergic reactions

    Severe allergic reactions

    What to do Consult your healthcare provider for guidance.

  • Risk of spinal cord compression (pressure on the spinal cord) in men whose cancer has spread

    Spinal cord compression risk in men with metastatic disease

    What to do Consult your healthcare provider for guidance.

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

Week by week

What should I expect from Leuprolide, and when?

  1. Early response

    You might notice
    • May experience tumor flare (temporary worsening) if used for cancer;
    • hot flashes and decreased libido begin
    What's normal
    • Full integration of Leuprolide into physiological systems is established
    • Long-term Leuprolide response remains personalized to your physiology
    • Leuprolide tolerance is well-maintained with consistent dosing
    What's next
    • Maintain your established Leuprolide protocol for sustained benefits
    • Continue periodic monitoring to confirm Leuprolide efficacy
    • Review comprehensive Leuprolide response with your provider

  2. Peak effect

    You might notice
    • Full testosterone suppression achieved;
    • endometriosis pain relief becomes noticeable;
    • tumor flare typically resolves
    What's normal
    • Leuprolide has achieved stable, long-term homeostatic integration
    • Sustained efficacy of Leuprolide remains consistent
    • Chronic Leuprolide effects remain stable and predictable
    What's next
    • Maintain your established Leuprolide protocol for sustained benefits
    • Continue periodic monitoring to confirm Leuprolide efficacy
    • Review comprehensive Leuprolide response with your provider

  3. Long term

    You might notice
    • Sustained hormone suppression;
    • continued symptom relief;
    • bone density monitoring becomes important;
    • most side effects stabilize
    What's normal
    • Full therapeutic effects of Leuprolide are well-characterized at this point
    • Maintenance of Leuprolide's therapeutic effects is typical
    • Tolerance patterns with Leuprolide are generally stable over months
    What's next
    • Comprehensive assessment of Leuprolide efficacy should be conducted
    • Discuss long-term continuation, cycling, or protocol modifications
    • Continue regular monitoring of relevant biomarkers or symptoms

How to tell it's actually working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Leuprolide over time
  • Reduction in symptom frequency or severity

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing anything? The usual reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

Is it right for you?

Who should avoid Leuprolide?

Do not use it if…

  • Pregnancy or breastfeeding (can harm the baby)
  • Undiagnosed vaginal bleeding
  • Active bone metastases (cancer that has spread to bone) with spinal cord compression (increased fracture risk)
  • Allergy to GnRH agonists (the drug class) or any ingredient
  • Severe heart disease with risk of QT prolongation (a heart rhythm problem)

Be extra careful if…

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Leuprolide use
  • You have any chronic health conditions that require regular monitoring

When to stop

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Leuprolide
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Leuprolide should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

What it mixes badly (and well) with

Medications

  • Avoid
    Other GnRH agonists (would cause overdosing)

    Use with caution—discuss with your healthcare provider.

  • Avoid
    Certain medications that prolong QT interval

    Use with caution—discuss with your healthcare provider.

  • Avoid
    Avoid if taking medications that significantly interact with testosterone suppression

    Use with caution—discuss with your healthcare provider.

Other peptides

  • OK together
    Anti-androgens (like bicalutamide) for prostate cancer

    May be used together under medical guidance.

  • OK together
    NSAIDs (like naproxen) for endometriosis pain

    May be used together under medical guidance.

  • OK together
    Bone-protecting agents (bisphosphonates) for long-term use

    May be used together under medical guidance.

Supplements

  • OK together
    Multivitamins

    Generally safe to take alongside Leuprolide. Space doses apart if taking oral formulations to ensure optimal absorption.

  • OK together
    Electrolyte supplements

    Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Who it tends to suit

Managing advanced or metastatic (spread to other parts of the body) prostate cancer

Leuprolide is particularly well-suited for individuals focused on managing advanced or metastatic prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 15.

Controlling severe endometriosis (womb-lining-type tissue growing outside the womb) pain

Leuprolide is particularly well-suited for individuals focused on controlling severe endometriosis pain. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 1.

Treating uterine fibroids (non-cancerous womb growths) that cause symptoms

Leuprolide is particularly well-suited for individuals focused on treating symptomatic uterine fibroids. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 1.

Delaying early puberty in children

Leuprolide is particularly well-suited for individuals focused on delaying early puberty in children. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 1.

The safety picture overall

Leuprolide (Lupron) is an FDA-approved GnRH agonist (a drug that first stimulates, then shuts down, sex-hormone production) with 35+ years of clinical safety data involving millions of patients in oncology and endocrinology. 1 The critical safety issue is the initial 5-7 day flare effect: a temporary surge in FSH/LH (the pituitary (the master hormone gland at the base of the brain) hormones that drive sex-hormone production) that worsens symptoms before hormone suppression begins. This is particularly dangerous for prostate cancer patients, since flare can cause urinary obstruction or spinal cord compression. 5 Bone density loss is a dose-dependent long-term risk in both men and women and needs monitoring. 15 Injection site reactions, hot flushes, and early low-sex-hormone symptoms (hypogonadal symptoms) are expected and typically temporary. 5

Leuprolide safety is well-established through FDA registration trials, extensive post-marketing surveillance, and hundreds of published clinical studies spanning endometriosis, prostate cancer, precocious puberty, and breast cancer indications. Long-term safety data from 10+ years of continuous therapy shows predictable hypogonadal effects with manageable metabolic consequences when monitored appropriately. 13 Black box warnings exist for flare risk in certain prostate cancer scenarios and bone loss risk in extended use.

Keeping it good

How do I store Leuprolide?

Before mixing (powder)

Store Leuprolide in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After mixing (liquid)

Once reconstituted, Leuprolide should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs it has gone bad

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Not our opinion — the published record

What the studies actually found about Leuprolide

2025

Leuprolide

Leuprolide, a GnRH agonist nonapeptide (a lab-made chain of nine amino acids that copies a brain hormone), is essential for managing prostate cancer, endometriosis, uterine fibroids, and precocious puberty (puberty that starts too early). It lowers sex hormones by making the pituitary gland stop responding (desensitization). More than four decades of clinical use has shown its safety and effectiveness as a cornerstone therapy for hormone-sensitive conditions.

Swayzer DV, Gerriets V

2022

Determination of Leuprolide-Fatty Acid Conjugate in Rat Plasma Using LC-MS/MS and Its Pharmacokinetics after Subcutaneous Administration in Rats

Researchers developed advanced analytical methods (lab tests) showing that attaching a fatty acid to leuprolide (fatty acid conjugation) greatly extends its half-life (how long it lasts in the body) and improves how the body handles it. These changes create longer-acting formulations, so patients can get the medicine less often through depot injections (slow-release shots).

Seong GS, Seo SW, Cho JY

2018

Gonadotropin Releasing Hormone (GnRH) Analogues

GnRH agonists, including leuprolide, deeply lower androgen and estrogen (sex hormone) levels without causing clinically significant liver damage. This makes them safe for long-term androgen deprivation therapy (treatment that lowers male hormones) in advanced prostate cancer and in benign (non-cancerous) hormone-responsive conditions.

National Institute of Diabetes and Digestive and Kidney Diseases (LiverTox)

2025

LUPRON DEPOT 3.75 mg (leuprolide acetate for depot suspension) — FDA label (DailyMed)

Indicated for managing endometriosis (womb-lining-type tissue growing outside the womb), including pain relief and shrinking of endometriosis lesions (patches of this tissue). It is also used with iron before surgery to improve anemia (low red blood cells) caused by fibroids (non-cancerous womb growths). Contraindicated (must not be used) with hypersensitivity (allergy) to GnRH or GnRH agonists, undiagnosed abnormal uterine bleeding, and pregnancy. Warnings: loss of bone mineral density (bone strength), some of which may not be reversible; depression may occur or worsen.

AbbVie / U.S. Food and Drug Administration

If this isn't the right fit

What people use instead of Leuprolide

Alternative approaches for hormone support support

  • Consult your healthcare provider for alternatives to Leuprolide based on your specific needs and medical history

Alternative hormone-supporting peptides

  • Kisspeptin-10
  • Gonadorelin
  • PT-141 (Bremelanotide)

Non-peptide hormone support

  • Clomiphene citrate
  • Anastrozole
  • Lifestyle modifications (sleep, exercise)

Your questions

Leuprolide FAQ

Is leuprolide a steroid?

No, leuprolide is not a steroid. It's a peptide hormone that works on your hormone system to reduce testosterone and estrogen production. It's similar to a natural brain hormone called GnRH 1.

Can I get pregnant while taking leuprolide?

No. Leuprolide significantly reduces fertility and is dangerous if you become pregnant. Women should use effective birth control during treatment. Some fertility may return after stopping, but this needs to be discussed with your doctor 15.

How long do I need to take leuprolide?

That depends on your condition. For prostate cancer, it's usually long-term or continuous. For endometriosis or fibroids, treatment typically lasts 3-12 months. Your doctor will determine the right duration for you 1.

What's the difference between daily and depot (slow-release) leuprolide?

Daily leuprolide is a shot you give yourself every day. Depot forms are longer-lasting injections given monthly, quarterly, or even yearly by a doctor. Depot is more convenient but can't be adjusted as quickly. Most people prefer depot forms 45.

Why do men get hot flashes from leuprolide?

When testosterone drops suddenly, your body's temperature regulation gets confused. This is your brain responding to the hormonal change. Hot flashes usually improve over time or can be managed with medication if needed 15.

7 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the Leuprolide research profile on Peptide Initiative.

  1. LeuprolideSwayzer DV, Gerriets V · 2025
  2. Determination of Leuprolide-Fatty Acid Conjugate in Rat Plasma Using LC-MS/MS and Its Pharmacokinetics after Subcutaneous Administration in RatsSeong GS, Seo SW, Cho JY · 2022
  3. Gonadotropin Releasing Hormone (GnRH) AnaloguesNational Institute of Diabetes and Digestive and Kidney Diseases (LiverTox) · 2018
  4. LUPRON (leuprolide acetate injection) Prescribing InformationAbbVie / U.S. FDA · 2017
  5. LUPRON DEPOT (leuprolide acetate for depot suspension) Prescribing InformationAbbVie / U.S. FDA · 2025
  6. LUPRON DEPOT 3.75 mg (leuprolide acetate for depot suspension) — FDA label (DailyMed)AbbVie / U.S. Food and Drug Administration · 2025
  7. LUPRON DEPOT-PED (leuprolide acetate for depot suspension) — FDA label (DailyMed)AbbVie / U.S. Food and Drug Administration · 2025

Want the deep science?

Read the full Leuprolide research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More hormones guides

This guide is education, not medical advice. Talk to a clinician before taking anything.